Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
BKYI Quote, Financials, Valuation and Earnings
Last price:
$0.84
Seasonality move
:
-6.36%
Day range:
$0.80 - $0.86
52-week range:
$0.52 - $3.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.38x
P/B ratio:
0.66x
Volume:
351.5K
Avg. volume:
596.1K
1-year change:
-55.33%
Market cap:
$4.8M
Revenue:
$6.9M
EPS (TTM):
-$2.08
Earnings Data
Next earnings date for BKYI
Aug 15
2025
Most recent earnings per share
-$0.16
Beat by $0.08
(May 16/2025)
Consensus Estimate
-$0.24
(May 16/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BKYI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.8M | -- | -- | -$0.16 | -- |
| 08/15/2025 | Q2 | $1.7M | -- | -- | -$0.15 | -- |
| 05/16/2025 | Q1 | $1.3M | $1.6M | -$0.16 | -$0.24 | $0.08 |
| 03/27/2025 | Q4 | $2.3M | $1.5M | -$0.53 | -$0.35 | -$0.18 |
| 11/15/2024 | Q3 | $1.6M | $2.1M | -$0.39 | -$0.58 | $0.19 |
| 08/15/2024 | Q2 | $2M | $1.1M | -$1.00 | -$0.54 | -$0.46 |
| 06/17/2024 | Q1 | -- | $2.2M | -$0.32 | -- | -- |
| 12/31/2023 | Q4 | -- | $1.8M | -$4.42 | -- | -- |
| 09/30/2023 | Q3 | $1.5M | $1.8M | -$3.22 | -$4.32 | $1.10 |
| 06/30/2023 | Q2 | $2.2M | $1.9M | -$4.71 | -$3.24 | -$1.47 |
| 03/31/2023 | Q1 | -- | $2.2M | -$3.51 | -- | -- |
| 12/31/2022 | Q4 | -- | $1.8M | -$11.16 | -- | -- |
| 09/30/2022 | Q3 | -- | $1.4M | -$5.22 | -- | -- |
| 06/30/2022 | Q2 | -- | $1.9M | -$3.78 | -- | -- |
| 05/13/2022 | Q1 | -- | $1.9M | -$2.34 | -- | -- |
| 12/31/2021 | Q4 | -- | $934.9K | -$4.68 | -- | -- |
| 11/12/2021 | Q3 | -- | $1.3M | -$2.34 | -- | -- |
| 08/13/2021 | Q2 | -- | $992.1K | -$2.70 | -- | -- |
| 05/14/2021 | Q1 | -- | $1.9M | -$1.98 | -- | -- |
| 03/09/2021 | Q4 | -- | $1.1M | -$3.24 | -- | -- |
| 11/12/2020 | Q3 | -- | $943.3K | -$9.18 | -- | -- |
| 08/14/2020 | Q2 | -- | $307.1K | -$10.80 | -- | -- |
| 03/31/2020 | Q1 | -- | $522.5K | -$33.12 | -- | -- |
| 12/31/2019 | Q4 | -- | $534.8K | -$13.09 | -- | -- |
| 09/30/2019 | Q3 | -- | $452.7K | -$18.72 | -- | -- |
| 06/30/2019 | Q2 | -- | $728.4K | -$14.40 | -- | -- |
| 03/31/2019 | Q1 | -- | $551.6K | -$18.72 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.7M | -$14.40 | -- | -- |
| 09/30/2018 | Q3 | -- | $739.8K | -$33.12 | -- | -- |
| 06/30/2018 | Q2 | -- | $748.1K | -$21.60 | -- | -- |
| 03/31/2018 | Q1 | -- | $841.5K | -$43.20 | -- | -- |
| 03/29/2018 | Q4 | -- | $3.1M | $5.76 | -- | -- |
| 09/30/2017 | Q3 | -- | $942.4K | -$40.32 | -- | -- |
| 06/30/2017 | Q2 | -- | $886.9K | -$46.08 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.4M | -$37.44 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.7M | -$17.28 | -- | -- |
| 09/30/2016 | Q3 | -- | $431.5K | -$34.56 | -- | -- |
| 06/30/2016 | Q2 | -- | $415.8K | -$41.76 | -- | -- |
| 03/31/2016 | Q1 | -- | $430.6K | -$36.00 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.7M | -$17.28 | -- | -- |
| 09/30/2015 | Q3 | -- | $669.9K | -$34.56 | -- | -- |
BIO-key International Earnings Questions
-
How Much did BIO-key International Generate in Revenue Last Quarter?
BIO-key International reported $1.6M worth of top line sales in its most recent quarter.
-
Did BIO-key International Beat Earnings Last Quarter?
BIO-key International announced earnings per share of -$0.16 which represents a beat of analyst forecast a -$0.24 per share.
-
Is BIO-key International Profitable?
BIO-key International reported $1.3M that represents $0.28 per share over the last quarter.
-
What is the Analyst Consensus for BIO-key International EPS Next Year?
BIO-key International's earnings are forecast to decrease from -$2.09 per share to -$1.86 per share next year representing a decrease of -73.68%.
-
When is BIO-key International's Earnings Date?
BIO-key International's next earnings date is August 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
